Contract facts
NONENo full NAICS 334516 intel page yet. Browse NAICS intelligence
15043761 MISEQ REAGENT KIT V3 150-CYCLE is a federal NONE award for Army Med Res Acq Activity held by Verogen, Inc. Estimated value $217K ($217K obligated). Current period of performance ends Mar 22, 2024. Last award drew 1 bidder. Place of performance: SAN DIEGO CA.
Recompete timing
PublicCurrent PoP ended Mar 22, 2024 (882 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942524F0079?
HT942524F0079 (15043761 MISEQ reagent KIT v3 150-cycle) is a Army Med Res Acq Activity award with a potential value of $217K, currently held by Verogen, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-24-F-0079?
HT9425-24-F-0079 is the dashed form of PIID HT942524F0079 (15043761 MISEQ reagent KIT v3 150-cycle), held by Verogen, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942524F0079?
Army Med Res Acq Activity awarded HT942524F0079 to Verogen, Inc (potential $217K).
Who is the incumbent on HT942524F0079?
Verogen, Inc is the incumbent. The current period of performance ends Mar 22, 2024.
When does Verogen, Inc’s HT942524F0079 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 22, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.